Exact Sciences (EXAS) Tops Q4 EPS by 6c, FY Rev. Guidance Beats
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
PMCB, CULP, HURC, More
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.44), $0.06 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $143 million versus the consensus estimate of $134.84 million.
GUIDANCE:
Exact Sciences sees FY2019 revenue of $710-730 million, versus the consensus of $704.35 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- BlackRock’s Rosenberg says inflation data key after jobs beat
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
